EW
TAK icon

Emerson Wealth’s Takeda Pharmaceutical TAK Stock Holding History

Emerson Wealth’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$13K Hold
952
– – 0.01% 50
2022
Q1 		$14K Hold
952
– – 0.01% 52
2021
Q4 		$13K Buy
+952
New +$13.4K 0.01% 43

Other funds holding TAK

MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Emerson Wealth's TAK Position: Q2 2022 in Review

Emerson Wealth held its Takeda Pharmaceutical (TAK) position steady in Q2 2022 at 952 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #50.

Emerson Wealth first reported a position in TAK in Q4 2021 and has held it in 3 quarters since. The position peaked at $14K in Q1 2022. 282 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

  • Emerson Wealth held 952 shares of Takeda Pharmaceutical worth $13K as of Q2 2022.
  • Emerson Wealth left its Takeda Pharmaceutical share count unchanged in Q2 2022.
  • Takeda Pharmaceutical made up 0.01% of Emerson Wealth's portfolio in Q2 2022, its #50 holding.
  • Emerson Wealth first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 3 quarters since.
  • Emerson Wealth's Takeda Pharmaceutical position peaked at $14K in Q1 2022.
  • 282 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Emerson Wealth's 13F filing for Q2 2022, filed 3 Aug 2022.